Estrogen-like effects of cadmium in vivo do not appear to be mediated via the classical estrogen receptor transcriptional pathway

Environmental Health Perspectives

Volumn 118, Issue 10, 2010, Pages 1389-1394

  Ali, Imran ^a   Penttinen Damdimopoulou, Pauliina E ^a,b   Mäkelä, Sari I ^b   Berglund, Marika ^a   Stenius, Ulla ^a   Åkesson, Agneta ^a   Håkansson, Helen ^a   Halldin, Krister ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Cadmium; Endocrine disruption; Estrogen receptors; Estrogen like effects; Metalloestrogens; Uterus

Indexed keywords

CADMIUM; CADMIUM CHLORIDE; ESTROGEN RECEPTOR; ETHINYLESTRADIOL; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN MDM2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BIOASSAY; BODY WEIGHT; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOMETRIUM; ESTROGEN ACTIVITY; ESTROGEN RESPONSIVE ELEMENT; EXPOSURE; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; IN VIVO STUDY; KIDNEY MASS; LIVER WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; UTERUS WEIGHT; VAGINA; VAGINA OPENING;

ANIMALS; BODY WEIGHT; CADMIUM; ENDOCRINE DISRUPTORS; ESTROGENS; FEMALE; MICE; ORGAN SIZE; RECEPTORS, ESTROGEN; TRANSCRIPTION, GENETIC;

MUS; RODENTIA;

EID: 77957926129     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1001967     Document Type: Article

References (54)

1. Acconcia F, Kumar R. 2006. Signaling regulation of genomic and nongenomic functions of estrogen receptors. Cancer Lett 238:1-14.
2. Ahlbory-Dieker DL, Stride BD, Leder G, Schkoldow J, Trolenberg S, Seidel H, et al. 2009. DNA binding by estrogen receptor-alpha is essential for the transcriptional response to estrogen in the liver and the uterus. Mol Endocrinol 23(10):1544-1555.
3. Alonso-Gonzalez C, Gonzalez A, Mazarrasa O, Guezmes A, Sánchez-Mateos S, Martínez-Campa C, et al. 2007. Melatonin prevents the estrogenic effects of sub-chronic administration of cadmium on mice mammary glands and uterus. J Pineal Res 42:403-410.
4. Amzal B, Julin B, Vahter M, Wolk A, Johanson G, Åkesson A. 2009. Population toxicokinetic modeling of cadmium for health risk assessment. Environ Health Perspect 117:1293-1301.
5. Åkesson A, Julin B, Wolk A. 2008. Long-term dietary cadmium intake and postmenopausal endometrial cancer incidence: a population-based prospective cohort study. Cancer Res 68(15):6435-6441.
6. Benbrahim-Tallaa L, Tokar EJ, Diwan BA, Dill AL, Coppin J-F, Waalkes MP. 2009. Cadmium malignantly transforms normal human breast epithelial cells into a basal-like phenotype. Environ Health Perspect 117:1847-1852.
7. Brama M, Gnessi L, Basciani S, Cerulli N, Politi L, Spera G, et al. 2007. Cadmium induces mitogenic signaling in breast cancer cell by an ERalpha-dependent mechanism. Mol Cell Endocrinol 264(1-2):102-108.
8. Branham WS, Zehr DR, Sheehan DM. 1993. Differential sensitivity of rat uterine growth and epithelium hypertrophy to estrogens and antiestrogens. Proc Soc Exp Biol Med 203(3):297-303.
9. Davis DL, Bradlow HL, Wolff M, Woodruff T, Hoel DG, Anton-Culver H. 1993. Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect 101:372-377.
10. Diel P, Schmidt S, Vollmer G. 2002. In vivo test systems for the quantitative and qualitative analysis of the biological activity of phytoestrogens. J Chromatogr B Analyt Technol Biomed Life Sci 777:191-202.
11. Duong V, Boulle N, Daujat S, Chauvet J, Bonnet S, Neel H, et al. 2007. Differential regulation of estrogen receptor α turnover and transactivation by Mdm2 and stress-inducing agents. Cancer Res 67(11):5513-5521.
12. Edwards DP. 2005. Regulation of signal transduction pathways by estrogen and progesterone. Annu Rev Physiol 67:335-376.
13. Elsenhans B, Kolb K, Schumann K, Forth W. 1994. The longitudinal distribution of cadmium, zinc, copper, iron, and metallothionein in the small-intestinal mucosa of rats after administration of cadmium chloride. Biol Trace Elem Res 41(1-2):31-46.
14. Filardo EJ, Quinn JA, Bland KI, Frackelton AR Jr. 2000. Estrogen induced activation of Erk1 and Erk2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 4:1649-1660.
15. Filardo EJ, Quinn JA, Frackelton AR Jr, Bland KI. 2002. Estrogen activation via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mdiated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol 16:70-84.
16. Fischer AH, Jacobson KA, Rose J, Zeller R. 2006. Preparation of cells and tissues for fluorescence microscopy. In: Basic Methods in Microscopy (Spector DL, Goldman RD, eds). New York: Cold Spring Harbor Laboratory Press, 105-124.
17. Fu XD, Simoncini T. 2008. Extra-nuclear signaling of estrogen receptors. IUBMB Life 60:502-510.
18. Höfer N, Diel P, Wittsiepe J, Wilhelm M, Degen GH. 2009. Dose- and route-dependent hormonal activity of the metalloestrogen cadmium in the rat uterus. Toxicol Lett 191(2-3):123-131.
19. Järup L, Åkesson A. 2009. Current status of cadmium as an environmental health problem. Toxicol Appl Pharmacol 238:201-208.
20. Jin YH, Clark AB, Slebos RJ, Al-Refai H, Taylor JA, Kunkel TA, et al. 2003. Cadmium is a mutagen that acts by inhibiting mismatch repair. Nat Genet 34(3):326-329.
21. Johnson MD, Kenney N, Stoica A, Hilakivi-Clarke L, Singh B, Chepko G, et al. 2003. Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Nat Med 9(8):1081-1084.
22. Kippler M, Goessler W, Nermell B, Ekström EC, Lönnerdal B, El Arifeen S, et al. 2009. Factors influencing intestinal cadmium uptake in pregnant Bangladeshi women-a prospective cohort study. Environ Res 109(7):914-921.
23. Legler J, van der Brink CE, Brouwer A, Murk AJ, van der Saag PT, Vethaak AD, et al. 1999. Development of stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line. Toxicol Sci 48:55-66.
24. Le Guevel R, Petit FG, Le Goff P, Metivier R, Valotaire Y, Pakdel F. 2000. Inhibition of rainbow trout (Oncorynchus mykiss) estrogen receptor activity by cadmium. Biol Reprod 63:259-266.
25. Lemmen JG, Arends RJ, van Boxtel AL, van der Saag PT, van der Burg B. 2004. Tissue- and time-dependent estrogen receptor activation in estrogen reporter mice. J Mol Endocrinol 32:689-701.
26. Levin ER, Pietras RJ. 2008. Estrogen receptors outside the nucleus in breast cancer. Breast Cancer Res Treat 108:251-261.
27. Liu Z, Yu X, Shaikh ZA. 2008. Rapid activation of ERK1/2 and AKT in human breast cancer cells by cadmium. Toxicol Appl Pharmacol 228:286-294.
28. McElroy JA, Shafer MM, Trentham-Dietz A, Hampton JM, Newcomb PA. 2006. Cadmium exposure and breast cancer risk. J Natl Cancer Inst 98:869-873.
29. Misra UK, Gawdi G, Akabani G, Pizzo SV. 2002. Cadmium-induced DNA synthesis and cell proliferation in macrophages: the role of intracellular calcium and signal transduction mechanisms. Cellular Signal 14:327-340.
30. Nilsson S, Mäkelä S, Treuter E, Tujague M, Thomsen J, Andersson G, et al. 2001. Mechanisms of estrogen action. Physiol Rev 81:1535-1565.
31. O'Brien JE, Peterson TJ, Tong MH, Lee E, Pfaff LE, Hewitt SC, et al. 2006. Estrogen-induced proliferation of uterine epithelial cells is independent of estrogen receptor α binding to classical estrogen response elements. J Biol Chem 281:26683-26692
32. OECD (Organisation for Economic Co-operation and Development). 2007. OECD Guidelines for the Testing of Chemicals. Test No. 440. Uterotrophic Bioassay in Rodents: A Short-Term Screening Test for Oestrogenic Properties. ENV/EPOC (2007)10. Paris: OCD.
33. Pääjärvi G, Viluksela M, Pohjanvirta R, Stenius U, Högberg J. 2005. TCDD activates Mdm2 and attenuates the p53 response to DNA damaging agents. Carcinogenesis 26(1):201-208.
34. Pedram A, Razandi M, Levin ER. 2006. Nature of functional estrogen receptors at the plasma membrane. Mol Endocrinol 20:1996-2009.
35. Penttinen P, Jaehrling J, Damdimopoulos AE, Inzunza J, Lemmen JG, van der Saag P, et al. 2007. Diet-derived polyphenol metabolite enterolactone is a tissue-specific estrogen receptor activator. Endocrinology 148:4875-4886.
36. Penttinen-Damdimopoulou PE, Power KA, Hurmerinta TT, Nurmi T, van der Saag PT, Mäkelä SI. 2009. Dietary sources of lignans and isoflavones modulate responses to estradiol in estrogen reporter mice. Mol Nutr Food Res 53:996-1006.
37. Persson I. 2000. Estrogens in the causation of breast, endometrial and ovarian cancers-evidence and hypotheses from epidemiological findings. J Steroid Biochem Mol Biol 74(5):357-364.
38. Razandi M, Alton G, Pedram A, Ghonshani S, Webb P, Levin ER. 2003a. Identification of structural detriment necessary for the localization and function of estrogen receptor alpha at the plasma membrane. Mol Cell Biol 23:1633-1646.
39. Razandi M, Pedram A, Merchanthaler I, Greene GL, Levin ER. 2004. Plasma membrane estrogen receptors exist and functions as dimmers. Mol Endocrinol 18:2854-2865.
40. Razandi M, Pedram A, Park ST, Levin ER. 2003b. Proximal events in signaling by plasma membrane estrogen receptors. J Biol Chem 278:2701-2712.
41. Reeves PG, Nielsen FH, Fahey GC Jr. 1993. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition and hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123(11):1939-1951.
42. Safe S. 2004. Endocrine disruptors and human health: is there a problem. Toxicology 205:3-10.
43. Santen RJ, Song RX, McPherson R, Kumar R, Adam L, Jeng MH, et al. 2002. The role of mitogen activated protein (MAP) kinase in breast cancer. J Steroid Biochem Mol Biol 80:239-256.
44. Satarug S, Garrett SH, Sens MA, Sens DA. 2010. Cadmium, environmental exposure, and health outcomes. Environ Health Perspect 118:182-190.
45. Siewit CL, Gengler B, Vegas E, Puckett R, Louie MC. 2010. Cadmium promotes breast cancer cell proliferation by potentiating the interaction between ERα and c-Jun. Mol Endocrinol 24(5): 981-992.
46. Silva E, Lopez-Espinoza MJ, Molina-Molina J, Fernandez M, Olea N, Kortenkamp A. 2006. Lack of activity of cadmium in in vitro estrogenicity assays. Toxicol Appl Pharmacol 216:20-28.
47. Slebos RJ, Li M, Evjen AN, Coffa J, Shyr Y, Yarbrough WG. 2006. Mutagenic effect of cadmium on tetranucleotide repeats in human cells. Mutat Res 602(1-2):92-99.
48. Stoica A, Katzenellenbogen BS, Martin MB. 2000. Activation of estrogen receptor-α by the heavy metal cadmium. Mol Endocrinol 14(4):545-553.
49. Vetillard A, Bailhache T. 2005. Cadmium: an endocrine disruptor that affects gene expression in the liver and brain of juvenile rainbow trout. Biol Reprod 72:119-126.
50. Zang R, Wang H. 2000. MDM2 oncogene as a novel target for human cancer therapy. Curr Pharm Des 6(4):393-416.
51. Zang Y, Odwin-DaCosta S, Yager JD. 2009. Effects of cadmium on estrogen receptor mediated signaling and estrogen induced DNA synthesis in T47D human breast cancer cells. Toxicol Lett 184(2):134-138.
52. Zhang W, Yang J, Wang J, Xia P, Xu Y, Jia H, et al. 2007. Comparative studies on the increase of uterine weight and related mechanisms of cadmium and p-nonylphenol. Toxicology 241(1-2):84-91.
53. Zheng H, Liu J, Liu Y, Klaassen CD. 1996. Hepatocytes from metallothionein-I and II knock-out mice are sensitive to cadmium- and tert-butylhydroperoxide-induced cytotoxicity. Toxicol Lett 87(2-3):139-145.
54. Zivadinovic D, Watson CS. 2005. Membrane estrogen receptor-α levels predict estrogen-induced ERK1/2 activation in MCF-7 cells. Breast Cancer Res 7(1):R130-R144.